ArgusEye
ArgusEye is a biotechnology company that provides sensor solutions for real-time detection of biological systems and processes. ArgusEye's patented sensor technology is the result of extensive academic research and is based on nanoplasmonic sensing with fiber optics. By adding customized receptors, ArgusEye can offer flexible and sensitivesensing systems for a variety of targets.
$3M
Latest Funding
Venture Round
Latest Funding Stage
2024-05-14
Funding Date
10
Employees
Sweden
Location
Linköping, Ostergotlands Lan
City & State
Sales-Ready Summary
ArgusEye recently secured $3M in venture funding and utilizes a tech stack including JavaScript libraries and databases, making them a potential target for vendors offering developer tools, database management solutions, or performance monitoring services.
Key Contacts
Open Positions
View Careers PageSimilar Startups
Quanta
Quanta provides software companies with real-time financial clarity and empowerment. Quanta envision a world in which all business accounting tasks that are not creative in nature are automated, leaving finance teams and business owners to focus solely on strategic and creative work.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.